Accessibility Menu
 
Fresenius SE & Co logo

Fresenius SE & Co

(ETR) FRE

Current Price$43.72
Market Cap$24.62B
Since IPO (1992)+6,282%
5 Year+16%
1 Year+9%
1 Month-14%

Fresenius SE & Co Financials at a Glance

Market Cap

$24.62B

Revenue (TTM)

$22.87B

Net Income (TTM)

$1.26B

EPS (TTM)

$2.24

P/E Ratio

19.48

Dividend

$1.00

Beta (Volatility)

-0.06 (Low)

Price

$43.72

Volume

771,054

Open

$44.14

Previous Close

$43.72

Daily Range

$43.66 - $44.39

52-Week Range

$31.60 - $52.96

FRE News

No articles available.

FRE: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Fresenius SE & Co

Industry

Healthcare Providers and Services

Employees

178,394

CEO

Michael Sen, MBA

Headquarters

Bad Homburg vor der Höhe, 61352, DE

FRE Financials

Key Financial Metrics (TTM)

Gross Margin

25%

Operating Margin

10%

Net Income Margin

6%

Return on Equity

8%

Return on Capital

7%

Return on Assets

3%

Earnings Yield

5.13%

Dividend Yield

0.02%

Payout Ratio

61.47%

Stock Overview

Market Cap

$24.62B

Shares Outstanding

563.24M

Volume

771.05K

Short Interest

0.00%

Avg. Volume

859.59K

Financials (TTM)

Gross Profit

$5.69B

Operating Income

$2.18B

EBITDA

$3.30B

Operating Cash Flow

$2.69B

Capital Expenditure

$1.50B

Free Cash Flow

$1.20B

Cash & ST Invst.

$1.58B

Total Debt

$11.93B

Fresenius SE & Co Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$6.16B

+9.3%

Gross Profit

$1.52B

+7.7%

Gross Margin

24.76%

N/A

Market Cap

$24.62B

N/A

Market Cap/Employee

$140.55K

N/A

Employees

175,202

N/A

Net Income

$361.00M

+50.4%

EBITDA

$844.00M

+1.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$10.35B

+10.3%

Accounts Receivable

$5.81B

+5.3%

Inventory

$2.61B

+1.5%

Long Term Debt

$10.46B

-3.2%

Short Term Debt

$1.47B

-46.9%

Return on Assets

3.05%

N/A

Return on Invested Capital

6.59%

N/A

Free Cash Flow

$619.00M

-6.5%

Operating Cash Flow

$1.34B

+40.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IDP.DEBiogen Inc.
$162.35-1.90%
PHI1.DEKoninklijke Philips N.V.
$23.44-1.06%
22UA.FBioNTech SE
$73.75-1.99%
ILU.DEIllumina, Inc.
$102.96-5.54%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About FRE

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.